This goal of this study is to determine if a new bone adhesive is useful in stabilizing dental tooth implants. Data collected from the study will examine the strength, performance, and the safety of the material.
This is an interventional trial involving an estimated 20 participants. All patients enrolled in study will receive the dental adhesive with a dental implant. The robustness of the dental implant stability will be assessed at various time points. The study began on September 27th 2019 and is estimated to be completed by November 27th 2021.
- Signed Informed Consent;
- 21+ Age;
- Require tooth extraction and replacement with dental implant;
- Have opposing dentition;
- Committed to Study and Follow-up period;
- ASA I or II;
- Planned “implant site” must have 1 adjacent tooth;
- Sufficient bone Height for safe dental implant placement;
- At least 2 mm of apical bone for seating of implant.
- Any significant disease that would preclude a dental implant
- Any oral surgery contraindications
- Subjects with mucosal Disease
- Subjects with bone diseases or conditions (e.g. Paget’s disease, fibrous dysplasia, history of osteomyelitis, etc.) in the region of the potential study implant site;
- Subjects with a history of local radiation therapy in the head/neck area or osteonecrosis of the jaws;
- Subjects with any acute and untreated endodontic lesions or periodontal disease;
- Subjects receiving, or having a recent or long-term history of receiving, oral or parenteral anti-osteoclastic agents [e.g., bisphosphonates, Xgeva® and Prolia® (denosumab); Forteo® (teriparatide), strontium ranelate, etc.], or anti-angiogenesis factors;
- Subjects who have major active substance abuse problems (e.g., alcoholism, opiate addiction, methamphetamine abuse, etc.);
- Subjects who are pregnant or intending to become pregnant during the duration of the study;
- Subjects who are heavy smokers (defined as >10 cigarettes per day or >1 cigar per day or equivalent of electronic cigarette vaping) or chew tobacco;
- Subjects with inadequate oral hygiene or who are unmotivated for adequate home care;
- Subjects who have physical or mental handicaps that would interfere with the ability to perform adequate oral hygiene;
- Subjects who have undergone administration of any investigational device within 30 days of enrollment in the study;
- Subjects who are allergic or otherwise sensitive to any materials likely encountered during the course of the study (e.g. titanium, suture materials, local anesthetics);
- Subjects with conditions or circumstances, which, in the opinion of the Investigator, would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability
- Any site into which the implant is not or cannot be placed during the same visit as the extraction;
- Any implant site where there is a dehiscence or fenestration of buccal or lingual plates of bone greater than 5mm in any direction.
This study is taking place at Pikos Institute, Trinity, Florida, United States, 34655. For further information please contact Michael Pikos, DDS on 727-781-0491 or at Learn@PikosInstitute.com.
This study is sponsored by LaunchPad Medical, with George Kay, DMD as the Principal Investigator.
Clinical TrialsView All Clinical Trials
The Eztetic Dental Implant System
This is an observational study in which patients in need of dental implants in the front regions of the maxilla or…
Short Dental Implants vs. Long Dental Implants
The purpose of this study is to evaluate the survival rate of 5 mm short implants compared to longer implants (10…
Comprehensive Alveolar and Tooth Esthetic Replacement
The purpose of this study is to evaluate whether including an allogeneic gum graft (a graft from an external donor)…
Impact of Laser-modified Abutment Topography on Peri-implant Mucosal Integration
This study is looking at the benefits of using a laser-etched abutment during dental implant treatment. An abutment…
Soft Tissue Dehiscence Around Implants
This study is looking at how to treat the problem of soft tissue dehiscences at implant sites. It is assessing the…